Search research articles
Contact Us
Filters
Showing results (131-140 of 184) with videos related to
Page
of 19
Sort By:
Current Opinion in Nephrology and Hypertension
|
July 1, 1994
Adynamic bone disease in patients with uremia
A Fournier, P H Yverneau, P Hué, et al.
Academic Medicine : Journal of the Association of American Medical Colleges
|
September 30, 2008
Speaking the right language: the scientific method as a framework for a continuous quality improvement program within academic medical research compliance units
Kurt B Nolte, Douglas M Stewart, Kevin C O'Hair, et al.
Journal for Immunotherapy of Cancer
|
July 7, 2019
Isolated neutropenia as a rare but serious adverse event secondary to immune checkpoint inhibition
Abdul Rafeh Naqash, Ebenezer Appah, Li V Yang, et al.
Nephron
|
January 1, 1986
Comparative evaluation of bone aluminum content and bone histology in patients on chronic hemodialysis and hemofiltration
J L Sebert, A Fournier, P Leflon, et al.
BMJ Open
|
February 16, 2024
Can RESPiratory hospital Admissions in children with cerebral palsy be reduced? A feasibility randomised Controlled Trial pilot study protocol (RESP-ACT)
Rachael Marpole, A Marie Blackmore, Andrew C Wilson, et al.
Neurobiology of Disease
|
July 25, 2006
The dynamism of PABPN1 nuclear inclusions during the cell cycle
A Marie-Josée Sasseville, Antoine W Caron, Lucie Bourget, et al.
Nephron
|
January 1, 1989
Disappearance of aluminic bone disease in a long term asymptomatic dialysis population restricting A1(OH)3 intake: emergence of an idiopathic adynamic bone disease not related to aluminum
P Morinière, M Cohen-Solal, S Belbrik, et al.
Clinical Therapeutics
|
October 9, 2007
Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects
A Marie O'Farrell, Andre van Vliet, Khalid Abou Farha, et al.
Experimental Neurology
|
June 9, 2009
Excitotoxic-mediated transcriptional decreases in HCN2 channel function increase network excitability in CA1
Brendan E L Adams, Christopher A Reid, Damian Myers, et al.
Nature Communications
|
November 19, 2017
Uplift of the central transantarctic mountains
Phil Wannamaker, Graham Hill, John Stodt, et al.
Page
of 19
Search research articles
Search
Showing results (131-140 of 184) with videos related to
Sort By:
Page
of 19
Current Opinion in Nephrology and Hypertension
|
July 1, 1994
Adynamic bone disease in patients with uremia
A Fournier, P H Yverneau, P Hué, et al.
Academic Medicine : Journal of the Association of American Medical Colleges
|
September 30, 2008
Speaking the right language: the scientific method as a framework for a continuous quality improvement program within academic medical research compliance units
Kurt B Nolte, Douglas M Stewart, Kevin C O'Hair, et al.
Journal for Immunotherapy of Cancer
|
July 7, 2019
Isolated neutropenia as a rare but serious adverse event secondary to immune checkpoint inhibition
Abdul Rafeh Naqash, Ebenezer Appah, Li V Yang, et al.
Nephron
|
January 1, 1986
Comparative evaluation of bone aluminum content and bone histology in patients on chronic hemodialysis and hemofiltration
J L Sebert, A Fournier, P Leflon, et al.
BMJ Open
|
February 16, 2024
Can RESPiratory hospital Admissions in children with cerebral palsy be reduced? A feasibility randomised Controlled Trial pilot study protocol (RESP-ACT)
Rachael Marpole, A Marie Blackmore, Andrew C Wilson, et al.
Neurobiology of Disease
|
July 25, 2006
The dynamism of PABPN1 nuclear inclusions during the cell cycle
A Marie-Josée Sasseville, Antoine W Caron, Lucie Bourget, et al.
Nephron
|
January 1, 1989
Disappearance of aluminic bone disease in a long term asymptomatic dialysis population restricting A1(OH)3 intake: emergence of an idiopathic adynamic bone disease not related to aluminum
P Morinière, M Cohen-Solal, S Belbrik, et al.
Clinical Therapeutics
|
October 9, 2007
Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects
A Marie O'Farrell, Andre van Vliet, Khalid Abou Farha, et al.
Experimental Neurology
|
June 9, 2009
Excitotoxic-mediated transcriptional decreases in HCN2 channel function increase network excitability in CA1
Brendan E L Adams, Christopher A Reid, Damian Myers, et al.
Nature Communications
|
November 19, 2017
Uplift of the central transantarctic mountains
Phil Wannamaker, Graham Hill, John Stodt, et al.
Page
of 19